What is the debt of I-Mab this year?
I-Mab has a debt level of 0 USD this year.
I-Mab Debt 2025
I-Mab Debt
0 USD
Ticker
IMAB
ISIN
US44975P1030
WKN
A2PVC6
In 2025, I-Mab's total debt was 0 USD, a -100% change from the -2,141.45 USD total debt recorded in the previous year.
I-Mab Aktienanalyse
What does I-Mab do?
I-Mab is a Chinese biopharmaceutical company specializing in the development of innovative therapies for the treatment of cancer and autoimmune diseases. It was founded in 2016 by Dr. Jingwu Zang and is based in Shanghai, China. I-Mab's business model focuses on the development of antibody therapies tailored to the needs of cancer and autoimmune patients. They utilize the latest research and development to create therapies that address the unmet market demand. They work on cancer immunotherapy, including CAR-T cell therapy, and also on immunotherapy for autoimmune diseases, including rare ones. Their goal is to improve the lives of patients with cancer and autoimmune diseases through innovative biotechnology and research. They have promising products in development and clinical trials, such as AMG 228 and TJM2. They aim to make a significant contribution to healthcare with their dedicated team of researchers and scientists. I-Mab ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding I-Mab's Debt Structure
I-Mab's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing I-Mab's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to I-Mab’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in I-Mab’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about I-Mab stock
What was the debt of I-Mab compared to the previous year?
The debt of I-Mab has increased by -100% compared to the previous year dropped.
What are the consequences of high debt for investors in I-Mab?
High debt can pose a risk for investors of I-Mab, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of I-Mab?
Low debt means that I-Mab has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from I-Mab affect the company?
An increase in debt of I-Mab can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of I-Mab affect the company?
A reduction in debt of I-Mab can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of I-Mab?
Some factors that can influence the debt of I-Mab include investments, acquisitions, operating costs, and revenue development.
Why are the debts of I-Mab so important for investors?
The debts of I-Mab are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can I-Mab take to change the debt?
To change the debt, I-Mab can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does I-Mab pay?
Over the past 12 months, I-Mab paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, I-Mab is expected to pay a dividend of 0 USD.
What is the dividend yield of I-Mab?
The current dividend yield of I-Mab is .
When does I-Mab pay dividends?
I-Mab pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of I-Mab?
I-Mab paid dividends every year for the past 0 years.
What is the dividend of I-Mab?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is I-Mab located?
I-Mab is assigned to the 'Health' sector.
Wann musste ich die Aktien von I-Mab kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of I-Mab from 10/8/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/8/2025.
When did I-Mab pay the last dividend?
The last dividend was paid out on 10/8/2025.
What was the dividend of I-Mab in the year 2024?
In the year 2024, I-Mab distributed 0 USD as dividends.
In which currency does I-Mab pay out the dividend?
The dividends of I-Mab are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von I-Mab
Our stock analysis for I-Mab Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of I-Mab Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
